Legal status · Canada
Is CJC-1295 with GHRP-6 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. CJC-1295 with GHRP-6 is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
CJC-1295 with GHRP-6 in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 3 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the CJC-1295 with GHRP-6 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing CJC-1295 with GHRP-6 is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What CJC-1295 with GHRP-6 is
The same two-receptor pairing as the GHRP-2 version with the hungriest secretagogue of the group in the second slot. GHRP-6 has published human pharmacokinetics in nine male volunteers, with an elimination half-life of about 2.5 hours, against a GHRH half that either lasts days or minutes depending on which molecule is actually in the vial. Nobody has studied the blend.
GHRP-6 is the original growth hormone releasing hexapeptide and the one with the strongest appetite effect in the family. That is why it persists in this market: people who want to eat choose it deliberately, and people who do not want to eat find out about it the hard way.
Mechanism: GHRP-6 is a hexapeptide agonist at the growth hormone secretagogue receptor, the ghrelin receptor, which triggers a growth hormone pulse and also drives appetite, and at higher exposures raises cortisol and prolactin more than the newer selective agents. The GHRH analogue raises pulse amplitude at a separate receptor.
Regulatory history: Not approved. GHRP-6 has been studied in Cuba for tissue protection indications but holds no marketing authorisation in the United States, and the combination has never been evaluated anywhere.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for CJC-1295 with GHRP-6 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
CJC-1295 with GHRP-6 in other countries
Frequently asked questions
Is CJC-1295 with GHRP-6 legal in Canada?
No. CJC-1295 with GHRP-6 is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Can I buy CJC-1295 with GHRP-6 in Canada?
No approved product exists to buy. In Canada CJC-1295 with GHRP-6 is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is CJC-1295 with GHRP-6 Health Canada approved?
No. In Canada CJC-1295 with GHRP-6 is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved. GHRP-6 has been studied in Cuba for tissue protection indications but holds no marketing authorisation in the United States, and the combination has never been evaluated anywhere.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for CJC-1295 with GHRP-6 live on its compound profile.
CJC-1295 with GHRP-6 profileThis page is general information about the regulatory status of CJC-1295 with GHRP-6 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.